MTD
Mettler-Toledo International
NYSE · Life Sciences Tools & Services
$1,373.57
-9.28 (-0.67%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 3.71B | 3.66B | 14.60B | 13.50B | 13.55B |
| Net Income | 827.02M | 734.26M | 1.07B | 1.09B | 931.82M |
| EPS | — | — | — | — | — |
| Profit Margin | 22.3% | 21.2% | 7.4% | 8.1% | 6.9% |
| Rev Growth | +1.4% | +1.4% | +20.5% | +2.4% | +8.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 13.86B | 13.86B | 10.32B | 12.19B | 12.25B |
| Total Equity | 170.62M | 170.62M | 19.66B | 20.56B | 19.45B |
| D/E Ratio | 81.23 | 81.23 | 0.53 | 0.59 | 0.63 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 1.14B | 1.06B | 1.87B | 1.78B | 1.90B |
| Free Cash Flow | — | — | 797.82M | 1.19B | 721.40M |